Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma

Article Properties
  • Language
    English
  • Publication Date
    2004/03/01
  • Indian UGC (journal)
  • Refrences
    36
  • Citations
    117
  • Jens Koopmann 1Departments of Pathology and
  • Neal S. Fedarko 3Division of Geriatrics, Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD
  • Alka Jain 3Division of Geriatrics, Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD
  • Anirban Maitra 1Departments of Pathology and
  • Christine Iacobuzio-Donahue 1Departments of Pathology and
  • Ayman Rahman 1Departments of Pathology and
  • Ralph H. Hruban 1Departments of Pathology and
  • Charles J. Yeo 2Surgery, Johns Hopkins Medical Institutions, Baltimore, MD and
  • Michael Goggins 1Departments of Pathology and
Abstract
Cite
Koopmann, Jens, et al. “Evaluation of Osteopontin As Biomarker for Pancreatic Adenocarcinoma”. Cancer Epidemiology, Biomarkers &Amp; Prevention, vol. 13, no. 3, 2004, pp. 487-91, https://doi.org/10.1158/1055-9965.487.13.3.
Koopmann, J., Fedarko, N. S., Jain, A., Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Hruban, R. H., Yeo, C. J., & Goggins, M. (2004). Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma. Cancer Epidemiology, Biomarkers &Amp; Prevention, 13(3), 487-491. https://doi.org/10.1158/1055-9965.487.13.3
Koopmann, Jens, Neal S. Fedarko, Alka Jain, Anirban Maitra, Christine Iacobuzio-Donahue, Ayman Rahman, Ralph H. Hruban, Charles J. Yeo, and Michael Goggins. “Evaluation of Osteopontin As Biomarker for Pancreatic Adenocarcinoma”. Cancer Epidemiology, Biomarkers &Amp; Prevention 13, no. 3 (2004): 487-91. https://doi.org/10.1158/1055-9965.487.13.3.
Koopmann J, Fedarko NS, Jain A, Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention. 2004;13(3):487-91.
Refrences
Title Journal Journal Categories Citations Publication Date
Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients Annals of Surgery
  • Medicine: Medicine (General)
  • Medicine: Surgery
  • Medicine: Medicine (General)
634 1995
Osteopontin is required for full expression of the transformed phenotype by the ras oncogene British Journal of Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
63 2000
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)

Science
  • Science: Science (General)
659 1996
10.1016/S1091-255X(00)80105-5
10.1016/S0889-8588(01)00007-7
Citations
Title Journal Journal Categories Citations Publication Date
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data eClinicalMedicine 16 2023
The role of circadian gene timeless in gastrointestinal cancers Gene Reports 2023
Screening for pancreatic cancer has the potential to save lives, but is it practical? Expert Review of Gastroenterology & Hepatology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
  • Medicine: Medicine (General)
2 2023
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma

JCO Clinical Cancer Informatics
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
2023
Progress on diagnostic and prognostic markers of pancreatic cancer Oncology Research
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
2 2023
Citations Analysis
The category Medicine: Medicine (General) 77 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Cancer in the elderly: pancreatic cancer and was published in 2004. The most recent citation comes from a 2023 study titled Earlier Diagnosis of Pancreatic Cancer: Is It Possible?. This article reached its peak citation in 2007, with 12 citations. It has been cited in 82 different journals, 13% of which are open access. Among related journals, the International Journal of Cancer cited this research the most, with 7 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year